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Abstract
α-Lipoic acid and L-carnosine are powerful antioxidants and are often used as a health supplement and as an ergogenic aid. The objective of
this study was to investigate the effects of α-lipoic acid and/or L-carnosine supplementation on antioxidant activity in serum, skin, and liver of 
rats and blood lipid profiles for 6 weeks. Four treatment groups received diets containing regular rat chow diet (control, CON), 0.5% α-lipoic acid
(ALA), 0.25% α-lipoic acid + 0.25% L-carnosine (ALA + LC), or 0.5% L-carnosine (LC). Superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) and lipid peroxidation products, malondialdehyde (MDA) concentrations, were analyzed in serum, skin, and liver. Blood lipid  profiles
were measured, including triglycerides (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol
(LDL-C). Skin and liver SOD activities of the ALA and LC groups were higher than those of the CON group (P< 0.05), but serum SOD activity
was higher only in the LC group compared to that in the CON group (P< 0.05). Additionally, only liver GSH-Px activity in the LC group was
higher than that of the CON and the other groups. Serum and skin MDA levels in the ALA and LC groups were lower than those in the CON
group (P< 0.05). Serum TG and TC in the ALA and ALA + LC groups were lower than those in the CON and LC groups (P< 0.05). The HDL-C
level in the LC group was higher than that in any other group (P< 0.05). LDL-C level was lower in the ALA + LC and LC groups than that 
in the CON group (P < 0.05). Thus, α-lipoic acid and L-carnosine supplementation increased antioxidant activity, decreased lipid peroxidation in
the serum, liver, and skin of rats and positively modified blood lipid profiles.
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Introduction7)
α-Lipoic acid (ALA) is a naturally occurring short chain fatty 
acid with sulfhydryl groups and a powerful micronutrient with 
various biological functions [1,2]. ALA functions as an E2 
subunit cofactor of the pyruvate dehydrogenase complex and α
-ketoglutarate dehydrogenase and is a potent scavenger of 
hydroxyl radicals, superoxide radicals, peroxyl radicals, singlet 
oxygen, and nitric oxide [3,4]. ALA also plays a role regenerating 
endogenous antioxidants such as coenzyme Q10, vitamin C, 
vitamin E, and glutathione and chelates metal ions and repairs 
oxidized proteins [1,5]. ALA is reduced by the cytosolic enzymes 
GSH-reductase and thioredoxin reductase, and also the E3 
mitochondrial enzyme dihydrolipoyl dehydrogenase. The mito-
chondrial E3 enzyme reduces ALA to DHLA at the expense of 
NAD(P)H [6]. ALA is also a substrate for the NADPH-dependent 
enzyme GSH-reductase [7].
Observations of ALA as an antioxidant in vitro and in vivo 
were previously based on hyperglycemic ambience [8-10]. 
However, no experimental design has addressed whether ALA 
could work against atherosclerosis in vivo; thus, preventing 
proliferation and propagation of this degenerative disease. Lipid 
peroxidation, the oxidative deterioration of polyunsaturated fatty 
acids, leads to the formation of hydroperoxides, short-chain 
aldehydes, ketones, and other oxygenated compounds. This 
process is responsible for the development of various diseases 
such as atherosclerosis [8], diabetes [11], cancer [12], and may 
be one of the main contributing factors in aging [13]. 
Free radical-mediated lipid peroxidation has been proposed to 
be critically involved in disease states including brain dysfunction, 
cardiovascular disease, and cancer as well as in the degenerative 
processes associated with aging. Enzymatic antioxidants such as 
superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) 
protect cell membranes from lipid peroxidation. ALA administered 
to aged rats replenishes glutathione, ascorbic acid, and alpha- 
tocopherol due to its capacity to enhance the levels of these 
antioxidants by reducing their radicals to repair oxidative damage. 
In contrast, the combination of two different antioxidants can 
be beneficial for limiting pathological processes in which excess 
production of free radicals may be involved and progress to 
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Group Type of diet
CON AIN - 93G diet
ALA AIN - 93G diet + 0.5 % α-lipoic acid
ALA+LC AIN - 93G diet + 0.25 % α-lipoic acid + 0.25 % L-carnosine
LC AIN - 93G diet + 0.5 % L-carnosine
CON,  Control;  ALA,  α-lipoic  acid  added  group;  ALA + LC,  α-lipoic  acid  and 
L-carnosine  added  group;  LC,  L-carnosine  added  group
Table 1. Experimental design
damage (e.g., diabetic neuropathy, Alzheimer’s disease, and 
cardiac ischemia). Some studies have suggested a possible synergistic 
effect of different non-enzymatic antioxidant compounds [14,15].
Human skin is constantly exposed to ultraviolet irradiation, 
which increases reactive oxygen species (ROS) production and 
leads to a number of pathological changes in the skin. A recent 
photoprotection strategy is to support the endogenous antioxidant 
system of the skin with natural substances through the diet or 
dermatological preparations. ALA easily penetrates the skin due 
to its lipid soluble characteristics in combination with a low 
molecular weight (206.3) [16]. Freisleben et al. [17] demons-
trated that topical ALA cream applied to hairless mice penetrates 
the epidermis and is distributed in the dermis and the subcutaneous 
tissue after 4 h. However, no studies have investigated the effects 
of dietary administration of ALA on changes in antioxidant 
activity in human skin, blood, and tissues [18].
L-carnosine (β-alanyl-L-histidine) (LC) is an endogenously 
synthesized peptide found in muscles, brain, and other tissues 
[19]. LC is a potent antioxidant
  [20] and has an important role 
as a pH buffer to protect against damage caused by oxidation 
under anaerobic respiration conditions. During exercise, carnosine 
suppresses acidification of intracellular environments and maintains 
muscle activity. It also decreases malonaldehyde (MDA)-induced 
lipid peroxidation by the combined actions of free radical 
scavenging and metal chelation. The protective effects of carnosine 
have been demonstrated by brain ischemia in two animal models.
LC dietary supplementation leads to increased concentrations 
in animal tissues, and high concentrations of LC in tissues delays 
diabetic deterioration in a mouse model by protecting low density 
lipoprotein (LDL) against methyl glycosylation and antioxidative 
activity [21]. LC is involved in blood glucose regulation [22] 
and has cardiovascular functions [8]. The combined effects of LC 
and alpha-tocopherol enhance antioxidative properties [23-25]. 
However, few reports are available on the interactions of 
antioxidants in an in vivo model. The synergistic or additive effect 
of other antioxidants with LC has not been investigated so far.
Thus, whether oral administration of ALA and/or LC is able 
to exert antioxidative effects in rats by reducing free radical 
formation, and the effects of combined dietary supplementation 
of different naturally occurring antioxidants have not been 
investigated. Therefore, the objectives of this study were to 
investigate the effects of ALA or LC supplementation and to 
examine the combined effects of ALA and LC on antioxidant 
activities and blood lipid profiles in high-fat fed rats.
Materials and Methods
Animals and diets
Forty male Sprague-Dawley rats were supplied by Hanlim 
Experimental Animal Laboratory (Seoul, Korea), (average body 
weight, 231.5 ± 8.0 g) and were randomly assigned to four groups 
of 10 rats each. The rats were kept individually in stainless-steel 
cages in a room controlled for temperature (22 ± 1℃), relative 
humidity (50-60%), and light (12-hour light/dark cycle). All 
experimental protocols followed established guidelines for the 
care and handling of laboratory animals and were approved by 
the Institutional Animal Ethics Committee of Chung-Ang University, 
Korea. After a 1 week adaptation period, the four groups were 
fed four different diets for 6 weeks. The control group (CON) 
was fed the AIN-93G diet [18]. The energy composition of 
AIN-93G diet is 64.0% from carbohydrate, 19.3% from protein, 
and 16.7% from fat. The ALA supplementation level was 
determined based on previous studies. It was reported that a 0.5% 
ALA diet reduces plasma MDA and blood lipids in Otsuka Long- 
Evans Tokushima Fatty rats [11], and that an intraperitoneal 
injection of ALA (35 mg/kg body weight) decreases lipid 
peroxidation [12]. We investigated carnosine supplementation 
(0.01, 0.1, and 1.0%) on muscle carnosine concentrations and 
hematological indices of rats prior to the study. The 0.1% and 
1.0% carnosine supplementation led to drop in blood LDL- 
cholesterol but an increase in HDL-cholesterol levels [26]. 
Groups receiving ALA or LC in this study were fed one of the 
following diets containing 0.5% ALA (ALA group), 0.25% ALA 
and 0.25% LC (ALA + LC group), or 0.5% LC (LC group). Table 
1 summarizes the experimental design 
The rats were allowed free access to the experimental diets 
and to deionized water. No significant differences in body weight 
were observed among the groups at the start of the experiment. 
Feed consumption was checked every other day, and body weight 
was measured weekly. After 6 weeks of ad libitum feeding, the 
animals were fasted overnight, anesthetized with a combination 
of ketamine (50 mg/kg) and xylazine (0.1 mg/kg), and sacrificed. 
The liver, heart, kidneys, and spleen were removed and weighed. 
Blood was collected immediately from the abdominal aorta, and 
the serum was obtained by centrifugation (3,000 rpm, 10 min, 
4℃). All samples were stored at -70℃ until analysis. 
Skin homogenates were prepared for the antioxidant activity 
measurements using the method of Kim and Lee [27]. The 
animals were shaved of hair on the back after dissection, and 
then the skin tissue was removed. Subcutaneous fat was removed 
from the skin tissue using a buffer (10 mM phosphate buffer, 
1.15% KCl, 5 mM EDTA, pH 7.4) at 4℃
  and then the skin 
tissue was cut into 0.5 g pieces. Ten volumes of 0.1 M phosphate 
buffer were added to each skin sample (0.5 g), which was then 
homogenized for 1 min at 4℃ and centrifuged at 5,000 rpm and 
4℃ for 30 min. Only the supernatant was used for the assay. Mi Young Kim et al. 423
Each supernatant sample was stored at -70℃ until analysis. To 
obtain the liver homogenates, 0.5 g of liver was combined with 
10 volumes of 0.1 M phosphate buffer, homogenized, and 
centrifuged at 6,000 rpm and 4℃ for 30 min. The supernatant 
was used for the lipid peroxidation assay. For SOD activity 
measurements, 1 ml of the supernatant was combined with 0.4 
ml of mixed ethanol and chloroform (5:3, v/v), and then centrifuged 
at 10,000 rpm and 4℃ for 30 min. The supernatant was used 
for SOD activity. To measure GSH-Px activity, the first supernatant 
from the homogenate after centrifugation at 6,000 rpm for 30 
min was re-centrifuged at 15,000 rpm and 4℃ for 50 min; this 
supernatant was used for the GSH-Px assay. All supernatant 
samples were stored at -70℃ until antioxidant activity analyses. 
Measurement of SOD activity
SOD activity was estimated using the method of Marklund 
and Marklund [28]. In a cap tube containing 0.2 ml of sample, 
2.6 ml of Tris EDTA HCl buffer (50 mM Tris, 10 mM EDTA, 
pH 8.5) was added and then mixed with 0.2 ml of 7.2 mM 
pyrogallol solution. After 10 min at 25℃, 0.1 ml of 1 N HCl 
was added to the tube and vortexed for several seconds. The 
absorbance of the solution was measured at 520 nm. One unit 
was the amount of enzyme required to cause 50% inhibition of 
pyrogallol oxidation, and SOD activity was expressed as unit/mg 
protein. 
Measurement of GSH-Px activity
GSH-Px activities in the serum, skin, and liver were determined 
using the method described by Flohé and Günzler [29]. In a tube, 
0.1 ml of sample was combined with 0.5 ml of 0.1 M sodium 
phosphate buffer (pH 7.0) containing 0.1 mM EDTA, 0.1 ml 
glutathione reductase, and 0.1 ml 10 mM GSH. After 10 min 
at 37℃, 0.1 ml 1.5 mM NADPH was added. Then, 0.1 ml 12 
mM cumene hydroperoxide was added to the reaction solution 
after 3 min. The decrease in absorbance of the solution was 
measured every min for 5 min at 340 nm. Values are expressed 
as unit/mg protein/min. 
Measurement of lipid peroxidation
The amount of MDA reacting with thiobarbituric acid (TBA) 
was measured by the method of Ohkawa et al. [30] in the serum, 
skin, and liver. Sample (0.2 ml), 0.2 ml of 8.1% sodium dodecyl 
sulfate, and 3 ml of 20% acetic acid containing 0.8% TBA were 
combined in a capped tube. Distilled water was added until the 
total volume was 4 ml. After reacting at 95℃
  for 60 min, the 
tube was cooled in a cold water bath and 1 ml of distilled water 
and 5 ml of n-butanol: pyridine (15:1, v/v) were added. The 
vortexed tube was centrifuged at 4,000 rpm for 20 min. The 
absorbance of the supernatant was measured at 532 nm. MDA 
content are expressed as nmol/mg protein. 
Determination of serum lipid profiles and liver function 
Serum lipid profiles (TG, total cholesterol, HDL-C, and 
LDL-C) were determined using an autoanalyzer (SPOTCEM
TM, 
Arkray, Tokyo, Japan). Aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) were measured using enzymatic 
kits (Asan Pharmaceutical, Seoul, Korea) based on the Reitman- 
Frankel method [31]. 
Statistical analysis
All data are expressed as means ± standard deviations using 
SPSS for Windows version 12.0 (SPSS, Inc., Chicago, IL, USA). 
The statistical analyses included a one-way analysis of variance, 
and mean differences were analyzed by Duncan’s multiple range 
test.  P-values < 0.05 were considered significant. 
Results
Body weight, feed intake, feed efficiency ratio, and organ weights
Table 2 shows the body weight, feed intake, feed efficiency 
ratio (FER), and organ weights of rats fed the four different diets 
for 6 weeks. No significant differences in initial body weight 
were observed among the groups; however, final body weights 
were lowest in the ALA group after 6 weeks (P < 0.05). The 
CON group had the highest final body weight (P> 0.05), which 
was similar to the final body weight of the LC group. The mean 
feed intake in the LC group was significantly higher than that 
in the CON and ALA groups (P < 0.05); the CON and ALA 
groups did not significantly differ from each other. The FER 
of the CON group was highest (P < 0.05) and that of the ALA 
group was lowest among the groups (P < 0.05). The feed intake 
amounts and FER of the groups supplemented with ALA tended 
to be lower than those of the other groups. Organ weights (per 
kg body weight) were highest in the ALA group, but liver, heart, 
and spleen weights did not differ significantly between the LC 
group and the CON group.
SOD activity
The highest SOD activities in the serum, skin, and liver were 
found in the LC group compared to those in the other groups 
(Table 3). The skin and liver SOD activities in the CON group 
were significantly lower than those of the groups fed the ALA 
or LC supplemented diets (P < 0.05). Although SOD activities 
in the skin and liver of the ALA group were significantly higher 
than those in the CON group, these activities were significantly 
lower in the ALA group than those in the LC supplemented 
groups, ALA + LC and LC (P < 0.05). 424 Lipoic acid and carnosine on antioxidant activity
Group
CON ALA ALA + LC  LC
Initial body weight (g) 230.8 ± 15.0 231.6 ± 6.1 231.8 ± 3.7 231.9 ± 1.4
Final body weight (g) 451.2 ± 41.7
c 352.7 ± 13.3
a 406.4 ± 16.6
b 441.3 ± 31.1
c
Weight change (g) 220.4 ± 30.1
c 121.2 ± 14.9
a 174.6 ± 17.0
a 209.4 ± 31.3
c
Mean food intake (g/day) 24.5 ± 1.8
a 24.8 ± 2.6
a 25.5 ± 0.8
ab 26.8 ± 0.8
b
FER (g weight gain/g feed) 0.214 ± 0.026
d 0.117 ± 0.016
a 0.163 ± 0.018
b 0.186 ± 0.028
c
Liver (g/kg body weight) 30.9 ± 1.5
a 38.1 ± 3.4
c 35.2 ± 2.6
b 31.3 ± 2.5
a
Heart (g/kg body weight) 3.14 ± 0.22
a 4.06 ± 1.04
b 3.14 ± 0.26
a 3.08 ± 0.36
a
Kidneys (g/kg body weight) 6.96 ± 0.54
a 8.26 ± 0.36
b 7.91 ± 0.75
b 7.76 ± 0.76
b
Spleen (g/kg body weight) 1.62 ± 0.21 2.00 ± 0.67 1.66 ± 0.36 1.74 ± 0.41
Values  are  expressed  as  means ± SD. 
Means  with  different  superscripts  in  the  same  row  are  significantly  different  by  Duncan’s  multiple  range  test  (P <0 . 0 5 ) .  
CON,  Control;  ALA,  α-lipoic  acid  added  group;  ALA + LC,  α-lipoic  acid  and  L-carnosine  added  group;  LC,  L-carnosine  added  group;  FER,  food  efficiency  rate.
Table 2. Body weight, food intake, feed efficiency, and organ weights 
Group
CON ALA ALA + LC LC
Lipid profiles
Triglyceride (mg/dl) 58.5 ± 12.0
c 40.4 ± 13.2
a 44.8 ± 15.5
ab 54.2 ± 13.2
bc
Total cholesterol (mg/dl) 71.7 ± 6.1
c 65.1 ± 4.0
b 57.2 ± 3.8
a 69.2 ± 4.4
bc
HDL-cholesterol (mg/dl) 33.5 ± 5.7
a 32.5 ± 3.7
a 31.8 ± 4.3
a 39.9 ± 4.7
b
LDL-cholesterol (mg/dl) 26.9 ± 6.6
b 24.6 ± 6.8
b 16.5 ± 3.4
a 18.5 ± 7.3
a
AST (unit/L) 31.2 ± 3.5 38.6 ± 14.1 40.4 ± 12.5 33.8 ± 16.3
ALT (unit/L) 39.9 ± 4.8
a 49.5 ± 4.5
b 48.9 ± 8.6
b 44.1 ± 10.9
ab
Values  are  expressed  as  means ± SD. 
Means  with  different  superscripts  in  the  same  row  are  significantly  different  by  Duncan’s  multiple  range  test  (P < 0.05).  AST,  aspartate  aminotransferase;  ALT,  alanine 
aminotransferase;  CON,  Control;  ALA,  α-lipoic  acid  added  group;  ALA + LC,  α-lipoic  acid  and  L-carnosine  added  group;  LC,  L-carnos i n e  a d d e d  g r o u p .
Table 4. Lipid profiles and AST and ALT concentrations in serum 
Group
CON ALA ALA + LC LC
SOD (unit/mg protein)
   S e r u m 7 . 6 9±3 . 4 7
a 8.35 ± 2.62
ab 7.75 ± 3.91
a 11.48 ± 4.11
b
   S k i n 3 . 8 5±2 . 8 6
a 8.77 ± 5.18
b 12.51 ± 2.98
c 15.84 ± 4.25
c
   Liver 2.17 ± 1.16
a 5.48 ± 3.01
b 7.92 ± 2.60
c 8.18 ± 2.31
c
GSH-Px (unit/mg protein/min)
   Serum 61.47 ± 5.14 63.04 ± 6.73 65.00 ± 5.48 64.47 ± 7.46
   Skin 34.41 ± 9.08 33.49 ± 14.19 28.50 ± 6.10 38.75 ± 13.19
   Liver 59.77 ± 14.71
ab 51.01 ± 26.59
a 58.99 ± 20.49
ab 74.01 ± 10.97
b
MDA (nmol/mg protein)
   S e r u m 4 . 7 2±1 . 8 6
b 2.42 ± 0.99
a 3.54 ± 1.66
ab 2.87 ± 1.35
a
   Skin 15.13 ± 7.05
b 8.03 ± 8.67
a 4.56 ± 3.72
a 3.87 ± 4.44
a
   Liver 7.23 ± 1.84 8.45 ± 4.40 7.34 ± 5.52 4.91 ± 1.41
Values  are  expressed  as  means ± SD. 
Means with different superscripts in the same row are significantly different by Duncan’s multiple range test (P < 0.05). CON, Control; ALA, α-lipoic acid supplemented group; 
ALA + LC, α-lipoic acid and L-carnosine supplemented group; LC, L-carnosine supplemented  group;  SOD,  superoxide  dismutase; GSH-Px, glutathione peroxidase; MDA, 
malondialdehyde
Table 3. SOD and GSH-Px activities and MDA concentrations in serum, skin, and liver of rats
GSH-Px activity
GSH-Px activities in the serum, skin, and liver are shown in 
Table 3. GSH-Px activities in the serum and skin were not 
significantly different among the groups. Only liver GSH-Px 
activity was highest in the LC group (P< 0.05), but no significant 
differences were observed in the CON, ALA, and or ALA + LC 
groups. 
Lipid peroxidation concentrations
The highest levels of MDA in the serum and skin were found 
in the CON group (Table 3). Serum MDA level in the CON 
group was significantly higher than that in the ALA and LC 
groups. Furthermore, the skin MDA level in the CON group was 
significantly higher than that of the other groups (P <0 . 0 5 ) .  
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no significant differences were found in liver MDA levels among 
the groups. 
Serum lipid profiles and liver function 
The lipid profiles and AST and ALT levels in the serum of 
rats fed ALA or LC supplemented diets are presented in Table 
4. Serum TG and TC levels were significantly lower in the ALA 
group compared to those in the CON group (P < 0.05), but no 
difference was observed between the CON and LC groups. No 
significant differences among the ALA, ALA + LC, and CON 
groups were observed for HDL-C, whereas HDL-C level was 
highest in the LC group (P < 0.05). LDL-C level was 
significantly lower in the ALA + LC and LC groups than that 
in the CON and ALA groups (P< 0.05). No significant difference 
in serum AST levels was observed among the groups, whereas 
serum ALT levels were significantly higher in the ALA and ALA
+ LC supplemented groups than those in the CON group. 
Discussion
A significant weight reduction was observed in ALA fed rats. 
Similar to our data, Prieto-Hontoria et al. [23] showed a reduction 
in body weight in Wistar rats treated with a lipoic acid 
supplemented high-fat diet for 56 days. They suggested that 
lipoic acid reduces feed intake and feed efficiency by inhibiting 
intestinal sugar transport and preventing body weight gain in lean 
and obese models. In contrast, Dicter et al. [24] showed 
contradictory data for glycogen synthesis in rat soleus muscle 
supplemented with LA. LA causes mitochondrial uncoupling and 
induces the production of reactive oxygen species. LA regulates 
glucose metabolism as a oxidant to inhibit glycogen synthesis 
in muscle. Glucose metabolism by LA is regulated differently 
in muscle. Because of these contradictory data, our data confirm 
the anti-obese effect of LA supplementation in rats.
This study was performed to investigate the effects of ALA 
and/or LC supplementation on antioxidant activities and blood 
lipid profiles in rats. The rats received diets containing 0.5% 
ALA, 0.5% LC, 0.25% ALA + 0.25% LC, and regular rat chow 
diet. The results showed that the groups receiving 0.5% ALA 
dietary supplementation had significantly reduced final body 
weight and FER compared to rats fed the control diet (P<0 . 0 5 ) . 
Shen et al. [32] reported that 0.5% and 1.0% ALA supplementa-
tion for 3 weeks resulted in a decrease in final mouse body weight 
and carcass weights as the levels of dietary ALA increased. They 
concluded that ALA supplementation caused the significant 
decrease in carcass fat, which, in turn, decreased carcass weight. 
Song et al. [33] suggested that the anti-obesity effect of a 0.5% 
ALA diet was possibly due to an increase in energy expenditure 
induced by the increased gene expression of uncoupling protein-1 
(UCP1) mRNA in brown adipose tissue, which generates body 
heat by non-shivering thermogenesis. In the current study, our 
results agreed with other reports pertaining to the effect of weight 
loss from dietary ALA supplementation, although we did not 
measure UCP 1 expression. Final body weight in the LC group 
did not differ from that in the CON group but was greater than 
that in the ALA group (P> 0.05). Dietary supplementation with 
a 5% LC diet seems to inhibit the growth of rats; however, a 
0.9% and 1.8% LC diet has no effects on growth [34]. Body 
weight in the ALA + LC group was in between that of the ALA 
and LC groups, indicating that 0.25% ALA was still sufficient 
to affect body weight loss and to cancel out the LC effect on 
body weight.
The organ weights relative to body weight in the antioxidant 
supplemented groups were different (P< 0.05), except for spleen 
weight. The mean weights per kg body weight of the liver, heart, 
and kidneys of rats fed the 0.5% ALA diet were significantly 
higher than those in the CON group. However, LC group organ 
weights were not significantly different with those of the CON 
group except for kidney weight. Such differences in organ 
weights might simply be due to lower body weights of the ALA 
group rather than due to any adverse effects of the treatments, 
as no growth failures or signs occurred during the experimental 
period. 
The effects of an imbalance between free radical generation 
and the defense system have been implicated in the pathogenesis 
of several disease states, such as cancer, atherosclerosis, diabetes 
mellitus, and Parkinson’s disease. Thus, antioxidant enzymes are 
influenced by oxidation status, and changes in their activity can 
serve as a biomarker for oxidative stress [35]. In the present 
study, SOD activities in the serum, skin, and liver of the LC 
group were significantly higher than those of rats in the CON 
and ALA groups. LC supplementation seemed to be more 
effective for increasing SOD activity than that of ALA 
supplementation, although SOD activities in the skin and liver 
of the ALA group were still significantly higher than those in 
the CON group. Significantly higher GSH-Px activity was only 
shown in the liver of the LC group compared to that in the other 
groups. A study conducted by Liu et al.
  [36] indicated that LC 
supplementation increases liver GSH-Px activity in ethanol- 
induced liver injured rats. ALA supplementation (100 mg/kg/day) 
in rats increases antioxidant enzyme activities, including SOD 
and GSH-Px in blood and tissue [37-39]. However, in the current 
study, no significant differences in GSH-Px activity in the serum, 
skin, or liver were observed following ALA supplementation 
when compared to the CON group, which might be due to the 
lower ALA and LC supplementation levels (12-14 mg/day) 
compared to the levels in previous studies [37-39]. Combined 
ALA and LC supplementation (ALA + LC group) showed 
synergistic effects for increasing skin and liver SOD and GSH-Px 
activities. 
Lipid peroxidation occurs when hydroxyl radicals attack fatty 
acid side chains of membrane phospholipids. Certain chromosomal 
aberrations and carcinogenesis may develop as a result of lipid 
peroxidation [40]. MDA is a product of lipid peroxidation, and 426 Lipoic acid and carnosine on antioxidant activity
TBARS, as indicated by the MDA concentration, serve as an 
oxidative damage index [41]. Zulkhairi et al.
  [42] reported that 
TBARS levels were significantly lower in an ALA treated group 
compared to those in an untreated group, which agrees with our 
results. In our study, ALA and LC supplementation significantly 
lowered serum and skin lipid peroxide levels as measured by 
MDA (P < 0.05), but not in the liver. These effects of LC 
supplementation might contribute to inhibiting atherosclerosis in 
blood vessels. Dobrota et al. [43] reported that LC exhibits a 
significant protective effect in brain tissue damaged by 
ischemic-reperfusion injury when it was administered to animals 
before an ischemic episode, and LC prevents higher lipid 
peroxidation in the brain membrane of patients with a stroke 
and increases the resistance of neuronal membranes to in vitro 
induced oxidation. In another study, LC treatment resulted in 
significant decreases in lipid peroxide levels in thioacetamide- 
induced oxidative stress and hepatotoxicity [44]. ALA supple-
mentation also appeared to be effective for reducing oxidative 
stress in the rats in our study. ALA supplementation markedly 
lowered oxidant production and the attendant increase in oxidative 
damage associated with aging by ameliorating mitochondrial 
decay with age [42]. Furthermore, ALA supplementation with 
carnitine improves antioxidant status and reduces TBARS levels 
[45]. In our study, the serum and skin MDA levels in the ALA
+ LC group were not significantly different compared to those 
of the ALA and LC groups. Thus, any synergistic effects by 
combined ALA and LC supplementation were not indicated by 
MDA levels, although the MDA values were in between these 
two groups. Determining SOD and GSH-Px activities and MDA 
concentrations reflects the level of oxygen free radical meta-
bolism and the extent of oxidative stress, as SOD and GSH-Px 
are the major antioxidant enzymes that eliminate free radicals 
and possess antioxidative stress functions. MDA is a lipid 
peroxidation product formed after free radical attack cell 
membranes. Supplementation with ALA and ALA + LC in this 
study improved SOD activities with reduced MDA levels in skin. 
Both SOD and GSH-Px activities increased significantly in the 
liver, and MDA concentrations decreased with LC supplementation. 
Therefore, ALA and/or LC contributed to antioxidant defense 
by improving SOD and GSH-Px activities and by reducing lipid 
peroxidation in the skin and liver of rats. The MDA levels tended 
to decrease with increased SOD and GSH-Px activity.
ALA supplementation decreased serum TG and TC levels 
significantly compared to those in the CON group, whereas ALA
+ LC and LC supplementation decreased serum LDL-C levels. 
Furthermore, LC supplementation lead to significantly increased 
HDL-C levels compared to those in other groups. Ford et al.
 
[46] reported that ALA supplementation induces a decrease in 
plasma TG levels in diabetic rats, but that TC and HDL-C levels 
do not differ. Although the mechanism of how ALA and LC 
reduce TG, TC, and LDL-C levels is unknown [47], it is likely 
via lipoprotein lipase activity [48] or through cholesterol 
metabolism by the liver [49]. Butler et al. [50] reported that ALA 
supplementation in diabetic rats offsets rises in blood and liver 
triglycerides by inhibiting liver lipogenic gene expression, 
lowering hepatic triglyceride secretion, and stimulating clearance 
of triglyceride-rich lipoproteins. Rashid et al. [51] reported that 
ALA inhibits LDL glycation in vitro, which promotes foam cell 
formation. Foam cells are hallmarks of atherosclerosis and play 
a critical role in the development of the disease [38,52]. 
Therefore, the evident decrease in blood lipids following ALA 
and LC supplementation could improve endothelial function, 
which could have beneficial effects for preventing cardiovascular 
diseases. 
Serum ALT concentrations were significantly higher in rats 
fed the ALA-supplemented diets than those of the CON (P <
0.05), and serum AST concentrations in the ALA and ALA +
LC groups tended to be higher than those in the CON and LC 
groups. However, the serum ALT and AST concentrations were 
within the normal range for rats [53]. Cremer et al. [54] reported 
that administering 31.6 or 61.9 mg ALA/kg body weight/day for 
4 weeks to rats does not result in any adverse effects, whereas 
a high-dose of 121 mg ALA/kg body weight is associated with 
slight alterations in liver enzymes and histopathological effects 
on the liver. Our results are in good agreement with other studies. 
In conclusion, our results suggest that ALA and/or LC 
contribute to antioxidant defense by increasing SOD and GSH-Px 
activities and by decreasing lipid peroxidation in the serum, skin, 
and liver of rats. LC supplementation resulted in better 
antioxidant activities compared to that of ALA supplementation, 
and synergistic effects by the combined supplementation of ALA 
and LC were indicated by skin and liver SOD activity. ALA 
and LC supplementation improved serum lipid profiles in rats, 
which may contribute to preventing cardiovascular diseases. 
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